Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Sign Up to like & getrecommendations! Published in 2018 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2018.03.006
Abstract: Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could… read more here.
Keywords: advances syndrome; common mechanisms; fragile syndrome; molecular advances ... See more keywords